People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Pharmaceuticals, Other Health Care, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| OptiNose, Inc. | — | Pharmaceuticals | Series B | $120.4M | $34.6M | 2010 |
| iWalk, Inc. | — | Other Health Care | Series B | $74.5M | $377.9M | 2009 |
| Bioscale Inc | — | Biotechnology | Series B | $44.7M | $747.7M | 2012 |
| Aspire Bariatrics, LLC | — | Other Health Care | Series B | $27.0M | $359.1M | 2010 |
| Aspire Bariatrics, Inc. | — | Other Health Care | Series A | $13.2M | $93.5M | 2014 |
| VisionScope Technologies LLC | — | Biotechnology | Series A | $10.3M | $227.8M | 2009 |
| Inventure, LLC | — | Pharmaceuticals | Seed | $6.0M | $411K | 2019 |
| Qualegen, LLC | — | Other | Seed | $1.5M | $27.9M | 2014 |
William F. Doyle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William F. Doyle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.